CVE-2026-62095 kutethemes CVE debrief

Who should care

Defenders and security teams responsible for Biolife installations should assess exposure and potential impact.

Why it matters

CVE-2026-62095 is a high-severity vulnerability affecting Biolife versions up to 3.2.3. Defenders should prioritize verifying exposure and assessing potential impact.

• Potential XSS attacks may require verification and monitoring
• Defenders should assess exposure and prioritize verification

Technical summary

CVE-2026-62095 is a high-severity unauthenticated Cross Site Scripting (XSS) vulnerability affecting Biolife versions up to 3.2.3. The vulnerability has a CVSS score of 7.1 and is considered high severity.

Defensive priority

Defenders should prioritize verifying exposure and assessing potential impact.

Recommended defensive actions

• Verify Biolife version and assess exposure
• Review and update vulnerable versions
• Monitor for potential XSS attacks

Evidence notes

The CVE record and NVD entry provide limited information about the vulnerability. Further verification is required to determine affected versions and potential impact.

Sources and references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.